Article Details

Soleno Therapeutics (NASDAQ:SLNO) Lowered to Hold at Zacks Investment Research

Retrieved on: 2021-12-12 08:08:38

Tags for this article:

Click the tags to see associated articles and topics

Soleno Therapeutics (NASDAQ:SLNO) Lowered to Hold at Zacks Investment Research. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 129,773 shares of the company's stock worth $120,000 after buying an additional 116,378 shares in the last quarter. Finally, ...

Article found on: etfdailynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up